Spots Global Cancer Trial Database for Clinical Study of Decitabine and Paclitaxel Combination Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Study of Decitabine and Paclitaxel Combination Therapy
Official Title: An Open-labelled, Parallel, Multiple Ascending Dose, Phase Ib Clinical Study of Decitabine and Paclitaxel Combination Therapy in Treating Patients With Metastatic and Locally Advanced Breast Cancer
Study ID: NCT03282825
Conditions
Study Description
Brief Summary: Phase Ib clinical study of Decitabine and Paclitaxel combination therapy
Detailed Description: An open-labelled, parallel, multiple ascending dose, phase Ib clinical study of Decitabine and Paclitaxel combination therapy in treating patients with metastatic and locally advanced breast cancer
Keywords
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Yonsei University Health System, Severance Hospital, Seoul, , Korea, Republic of
Contact Details
Name: Joo Hyuk Sohn, MD, PhD
Affiliation: Yonsei University Health System, Severance Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
